Related Experiment Video
Updated: May 2, 2026

Computerized Adaptive Testing System of Functional Assessment of Stroke
Published on: January 7, 2019
Improved utilization of ADAS-cog assessment data through item response theory based pharmacometric modeling
Sebastian Ueckert1, Elodie L Plan, Kaori Ito
1Pharmacometrics Research Group Department of Pharmaceutical Biosciences, Uppsala University, P.O. Box 591, SE-751 24, Uppsala, Sweden, sebastian.ueckert@farmbio.uu.se.
This study enhances Alzheimer's disease (AD) trial analysis by combining item response theory (IRT) and pharmacometric modeling. This approach offers a more powerful and precise method for utilizing ADAS-cog data compared to traditional scoring.
Area of Science:
- Pharmacometrics
- Psychometrics
- Clinical Trial Analysis
Background:
- Alzheimer's disease (AD) clinical trials often rely on the ADAS-cog scale for primary outcome assessment.
- Improved analytical methods are needed to maximize the information derived from ADAS-cog data in mild to moderate AD populations.
Purpose of the Study:
- To investigate enhanced utilization of Alzheimer's Disease Assessment Scale-Cognitive (ADAS-cog) data.
- To combine pharmacometric modeling with item response theory (IRT) for improved AD trial analysis.
Main Methods:
- Developed a baseline IRT model for ADAS-cog using data from 2,744 individuals.
- Extended the IRT model using pharmacometric methods to analyze longitudinal ADAS-cog scores from 322 patients over 18 months.
- Assessed item sensitivity and drug effect detection power using the IRT model compared to total score methods.
Main Results:
- The IRT model effectively described both baseline and longitudinal ADAS-cog data at item and total score levels.
- Quantitatively characterized and ranked the information content of ADAS-cog items across different patient populations (mild cognitive impairment, mild AD).
- Clinical trial simulations demonstrated significantly higher power to detect drug effects with the IRT method versus traditional analysis.
Conclusions:
- A combined framework of IRT and pharmacometric modeling provides a more effective and precise analysis of ADAS-cog data.
- This integrated approach significantly increases the value and utility of ADAS-cog data in Alzheimer's disease clinical trials.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacokinetic–Pharmacodynamic Relationship: Problems